A significant number of life-threatening complications in pregnant women with heart disease could be prevented altogether, according to new findings published by the Journal of the American College of Cardiology.
A patient’s e-cigarette interfered with their implantable cardioverter-defibrillator (ICD) and prevented the device from properly functioning, according to a new analysis published in HeartRhythm Case Reports.
Researchers at Imperial College London have developed a new type of sensor that can track vital signs in both humans and animals, suggesting the ever-growing wearables trend is expanding to include pets and livestock.
A study published Feb. 25 in Circulation suggests wearables are useful for detecting CV abnormalities like atrial fibrillation, but there’s still a long way to go before they can be trusted for clinical management.
A secondary analysis of the AUGUSTUS trial confirms earlier findings that treating heart patients with the anticoagulant apixaban results in less major bleeding, hospitalization and death than warfarin, a standard-of-care blood thinner.